DR_SEQAN: Software for Evaluating HIV Drug Resistance
Author Information
Author(s): César Garriga, Luis Menéndez-Arias
Primary Institution: Centro de Biología Molecular 'Severo Ochoa', Consejo Superior de Investigaciones Científicas – Universidad Autónoma de Madrid
Hypothesis
The study aims to develop a software tool that accurately interprets HIV drug resistance mutations.
Conclusion
DR_SEQAN is an effective tool for interpreting HIV genotypic resistance and provides consistent predictions with existing algorithms.
Supporting Evidence
- DR_SEQAN provides expert advice on HIV genotypic resistance interpretation.
- The program's predictions are consistent with phenotypic data.
- It includes a database of drug susceptibility data from published studies.
Takeaway
DR_SEQAN is a computer program that helps doctors understand how HIV mutations affect drug resistance, making it easier to choose the right treatment.
Methodology
The software analyzes RT and PR sequences of HIV-1, predicts drug resistance using a rule-based algorithm, and compares results with phenotypic data.
Limitations
The program may not detect variants that comprise less than 20% of the total virus population.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website